This invention is directed generally to compositions (including foods, nutritional supplements, treats, and toys) for animal consumption that comprise omega-3 and omega-6 polyunsaturated fatty acids, and particularly compositions that tend to aid in reducing mitogen-activated-protein ("MAP") kinase activity in animals. This invention also is directed generally to the use of such compositions for reducing MAP kinase activity in animals and for treating a cancer or tissue hyperplasia.
